What are the recommendations for managing patients with cross-reactivity to one type of iron infusion?

The evidence shows that managing cross-reactivity to iron infusions involves immediate cessation of any reaction-inducing infusion, consideration of an alternative iron formulation, and prepared management of hypersensitivity reactions, particularly anaphylaxis, with close patient monitoring.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-18
DOI
https://doi.org/10.5281/zenodo.24336627
Primary Topic
Drug-Induced Adverse Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What are the recommendations for managing patients with cross-reactivity to one type of iron infusion?

Tripdatabase
3 links
Zenodo (CERN European Organization for Nuclear Research)
Drug-Induced Adverse Reactions
article

What are the recommendations for managing patients with cross-reactivity to one type of iron infusion?

Tripdatabase
article en

Abstract

The evidence shows that managing cross-reactivity to iron infusions involves immediate cessation of any reaction-inducing infusion, consideration of an alternative iron formulation, and prepared management of hypersensitivity reactions, particularly anaphylaxis, with close patient monitoring.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Drug-Induced Adverse Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon